AB0259 FOUR COMORBIDITY INDEXES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS. (June 2019)

• Record Type: Journal Article
• Authors: Huang, Yun-Ju; Kuo, Chang-Fu; Chen, Jung-Sheng; Luo, Shue-Fen
• Is Part Of: Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
• Page Start: 1586
• Page End: 1587
• Publication Date: 2019-06
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2019-eular.4513
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: Previous studies have reported an increased risk of multiple comorbidities in people with RA therefore it is necessary to systematically quantify the comorbidity burden of these patients.[1] The comorbidity index is a tool developed under this concept and has multiple clinical and research uses. Objectives: We compared four comorbidity indexes and mortality rate in patients with rheumatoid arthritis in Taiwan (Charlson Comorbidity Index (CCI), Elixhauser Comorbidity Index (ECI), Mutimorbidity index (MMI), Rheumatic Disease Comorbidity Index (RDCI)) Methods: All patients with rheumatoid arthritis diagnosed during 1998-2008 in Taiwan were identified using the Taiwan National Health Insurance Database and followed up to 31 Dec 2013. One-year mortality rate and 5-year mortality rate were compared using CCI, ECI, MMI and RDCI. High risk group for each index was defined as around the top 20% patients. A discrimination analysis was performed to compare the predictive ability of the model against the base model using the change of Harrell's c-statistics and the Akaike information criterion (AIC). Results: Among 24767 patients with rheumatoid arthritis, median age at diagnosis is 51 years old and female is 79.2%. The one-year and 5-year mortality rate (per 1000 people) is 41 vs. 177 in CCI, 43 vs. 135 in ECI, 43 vs. 169 in MMI, 43 vs. 159 in RDCI. (Low risk group vs. high risk group) The one-year and 5-year mortality rates all are higher in the high risk group compared with low risk group using four comorbidity indexes. The 5-year mortality rate rises up rapidly both in low risk group and high risk group using four comorbidity indexes. The discrimination analysis showed MMI predicted one-year and 5-year mortality best. (Harrell's c-statistics 0.796 in one-year mortality and 0.802 in 5-year mortality) ECI, MMI and RDCI are all good at predicting mortality as well. Conclusion: Our study showed mortality rate increased in patients after rheumatoid arthritis was diagnosed. All four comorbidity index score during diagnostic period predicted one-year and 5-year mortality rate well both in high risk and low risk group. Clinicians should screen different comorbidities, determine primary prevention and control disease activity to improve the functional status, quality of life and mortality of rheumatoid arthritis, especially in the patients with initial high comorbidity index scores. Reference: [1] Baillet, A., et al., Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis, 2016. 75(6): p.965-73. Base model included age, gender, income quartiles, urbanization and occupation groups. The Harrell's c-statistic indicates model prediction as the followings: 0.5 (as well as chance), 0.7–0.8 (acceptable), 0.8–0.9 (excellent), and 0.9–1 (outstanding prediction). The AIC statistic was calculated, and a small AIC indicates better prediction of the model. Disclosure of Interests: None declared